{"id":"147d21e6-156e-4908-93d3-0d85a668a1f5","modelId":"507fabb9-64cd-4561-9d52-4f536c2aaf09","versionId":null,"locationId":"948ed3c5-555a-4309-b2af-132ec91c984e","operatorId":"55a81e13-fb85-4bd8-8951-c16d2bd50eff","ownerId":null,"slug":"vitestro-aletta-nieuwegein-netherlands","status":"operational","firstSeen":"2024-01-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["security_patrol"],"shiftStructure":null,"hoursPerDay":10,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"medium_11_100","siteEnvironment":"indoor","operatorType":null,"sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://vitestro.com/news/dutch-leading-st-antonius-hospital-to-deploy-two-vitestro-blood-drawing-devices/","title":"Dutch leading St. Antonius Hospital to deploy two Vitestro blood drawing devices"}],"notes":"CE-marked blood-drawing robot deployed at St. Antonius Hospital (2 devices) and other Dutch hospitals. FDA authorized. 2027 broader commercial launch targeted.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"retail","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-21T04:11:43.487Z","updatedAt":"2026-08-21T14:21:22.455Z","model":{"id":"507fabb9-64cd-4561-9d52-4f536c2aaf09","companyId":"55a81e13-fb85-4bd8-8951-c16d2bd50eff","modelName":"Aletta","slug":"vitestro-aletta","description":"Aletta is Vitestro's autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to identify a suitable vein, guide needle insertion, and collect diagnostic blood samples; clinical trials reported about 94.5% first-stick success, with EU MDR approval.","formFactor":"service","industryVertical":null,"environment":null,"maturityStage":"research","lifecycleState":"active","supersededByModelId":null,"specs":{"class":"autonomous robotic phlebotomy device","success":"~94.5% first-stick"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://vitestro.com/aletta/","sourceName":"Vitestro"},{"url":"https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-its-kind-robotic-blood-draw-device","title":"FDA authorizes first-of-its-kind robotic blood draw device","sourceName":"U.S. Food and Drug Administration"},{"url":"https://www.instagram.com/reel/Dd4S8z6gytB/","title":"Vitestro Aletta drawing blood from real patients; NIR/ultrasound/Doppler (uncover.robotics via Instagram)","sourceName":"Instagram (@uncover.robotics / via Deploy.Report digest)","publishedAt":"2026-09-29"}],"aliases":["Vitestro Aletta"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Autonomy level","value":"Autonomous"},{"label":"Sensor suite","value":"AI and ultrasound imaging"},{"label":"First-stick success","value":"~94.5%"},{"label":"Regulatory approval","value":"EU MDR"},{"label":"End-to-end robotic blood draw","value":"Vitestro describes Aletta as an autonomous device that identifies a vein, inserts the needle, and collects blood into tubes for diagnostic testing (Vitestro Aletta)."},{"label":"US authorization","value":"The FDA announced De Novo authorization for Vitestro's autonomous robotic blood-draw device, the first of its kind authorized for the stated outpatient use (FDA robotic blood draw)."}],"createdAt":"2026-06-24T05:34:01.855Z","updatedAt":"2026-10-10T01:23:15.543Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":"autonomous","autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"55a81e13-fb85-4bd8-8951-c16d2bd50eff","name":"Vitestro","slug":"vitestro","description":"Dutch medical-robotics company; maker of Aletta, billed as the World's first autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to locate veins and draw blood, with ~94.5% first-stick success and EU MDR approval. Private.","status":"private","founded":null,"hq":"Nieuwegein, Netherlands","hqLat":52.0298704,"hqLng":5.0929334,"hqGeocodedAt":"2026-08-05T14:54:00.053Z","hqAddress":null,"hqPrecision":null,"website":"vitestro.com","fundingTotal":"70000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://vitestro.com/aletta/","title":"Vitestro Aletta phlebotomy robot"},{"url":"https://vitestro.com/news/vitestro-receives-fda-de-novo-authorization-for-aletta/","title":"Vitestro Receives FDA De Novo Authorization for Aletta","sourceName":"Vitestro"},{"url":"https://www.instagram.com/reel/Dd4S8z6gytB/","title":"Vitestro Aletta drawing blood from real patients; NIR/ultrasound/Doppler (uncover.robotics via Instagram)","sourceName":"Instagram (@uncover.robotics / via Deploy.Report digest)","publishedAt":"2026-09-29"}],"keyFacts":[{"label":"Aletta","value":"An autonomous robotic phlebotomy device (ARPD), the company's medical robotics product."},{"label":"Technology (company-claimed)","value":"Combines near-infrared, ultrasound and Doppler ultrasound imaging with robotics and AI to locate veins, guide needle insertion and collect blood samples."},{"label":"First-stick success rate","value":"About 94.5%."},{"label":"Europe (company-claimed)","value":"Aug 2026: CE-marked under EU MDR and in clinical and pre-commercial use in Europe, where commercial deployment comes first."},{"label":"FDA De Novo (company-claimed)","value":"Aug 2026: The FDA granted De Novo authorization, a new device classification; Vitestro calls it the first US clearance for a fully autonomous blood draw system."},{"label":"US plans (company-claimed)","value":"Aug 2026: Plans a US multicenter clinical trial before US commercial availability."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-24T05:33:59.935Z","updatedAt":"2026-10-21T00:48:47.997Z"}},"version":null,"location":{"id":"948ed3c5-555a-4309-b2af-132ec91c984e","name":"Nieuwegein, Netherlands","slug":"nieuwegein-netherlands","kind":"hospital","parentLocationId":null,"region":"Western Europe","lat":null,"lng":null,"reviewStatus":"unreviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-21T04:10:51.219Z","updatedAt":"2026-08-21T04:10:51.219Z"},"operator":{"id":"55a81e13-fb85-4bd8-8951-c16d2bd50eff","name":"Vitestro","slug":"vitestro","description":"Dutch medical-robotics company; maker of Aletta, billed as the World's first autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to locate veins and draw blood, with ~94.5% first-stick success and EU MDR approval. Private.","status":"private","founded":null,"hq":"Nieuwegein, Netherlands","hqLat":52.0298704,"hqLng":5.0929334,"hqGeocodedAt":"2026-08-05T14:54:00.053Z","hqAddress":null,"hqPrecision":null,"website":"vitestro.com","fundingTotal":"70000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://vitestro.com/aletta/","title":"Vitestro Aletta phlebotomy robot"},{"url":"https://vitestro.com/news/vitestro-receives-fda-de-novo-authorization-for-aletta/","title":"Vitestro Receives FDA De Novo Authorization for Aletta","sourceName":"Vitestro"},{"url":"https://www.instagram.com/reel/Dd4S8z6gytB/","title":"Vitestro Aletta drawing blood from real patients; NIR/ultrasound/Doppler (uncover.robotics via Instagram)","sourceName":"Instagram (@uncover.robotics / via Deploy.Report digest)","publishedAt":"2026-09-29"}],"keyFacts":[{"label":"Aletta","value":"An autonomous robotic phlebotomy device (ARPD), the company's medical robotics product."},{"label":"Technology (company-claimed)","value":"Combines near-infrared, ultrasound and Doppler ultrasound imaging with robotics and AI to locate veins, guide needle insertion and collect blood samples."},{"label":"First-stick success rate","value":"About 94.5%."},{"label":"Europe (company-claimed)","value":"Aug 2026: CE-marked under EU MDR and in clinical and pre-commercial use in Europe, where commercial deployment comes first."},{"label":"FDA De Novo (company-claimed)","value":"Aug 2026: The FDA granted De Novo authorization, a new device classification; Vitestro calls it the first US clearance for a fully autonomous blood draw system."},{"label":"US plans (company-claimed)","value":"Aug 2026: Plans a US multicenter clinical trial before US commercial availability."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-24T05:33:59.935Z","updatedAt":"2026-10-21T00:48:47.997Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/vitestro-aletta-nieuwegein-netherlands","url":"https://registry.deploy.report/deployments/vitestro-aletta-nieuwegein-netherlands","name":"Aletta at Nieuwegein, Netherlands","identifier":"147d21e6-156e-4908-93d3-0d85a668a1f5","startDate":"2024-01-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/nieuwegein-netherlands","name":"Nieuwegein, Netherlands"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/vitestro","name":"Vitestro"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/vitestro-aletta","name":"Aletta"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"research","lifecycle_state":"active","architectural_position":{"cohort":"service","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}